Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构：
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP03.03-02
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [21] Multi-Omics Uncovers Signatures Associated with Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients
    Braune, E. -B.
    Eide, I. J. Zwicky
    Grundberg, O.
    De Petris, L.
    Brustugun, O. T.
    Ekman, S.
    Hydbring, P.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S623 - S623
  • [22] Multi-omics models for predicting prognosis in non-small cell lung cancer patients following chemotherapy and radiotherapy: A multi-center study
    Pan, Yuteng
    Shi, Liting
    Liu, Yuan
    Chen, Jyh-cheng
    Qiu, Jianfeng
    RADIOTHERAPY AND ONCOLOGY, 2025, 204
  • [23] A Critical Review of the Prognostic and Predictive Implications of KRAS and STK11 Mutations and Co-Mutations in Metastatic Non-Small Lung Cancer
    Manolakos, Peter
    Ward, Linda D.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (06):
  • [24] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [25] STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
    Pons-Tostivint, Elvire
    Lugat, Alexandre
    Fontenau, Jean-Francois
    Denis, Marc Guillaume
    Bennouna, Jaafar
    CELLS, 2021, 10 (11)
  • [26] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [27] Immune-based Therapies for Non-small Cell Lung Cancer
    Rafei, Hind
    El-Bahesh, Ehab
    Finianos, Antoine
    Nassereddine, Samah
    Tabbara, Imad
    ANTICANCER RESEARCH, 2017, 37 (02) : 377 - 387
  • [28] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [29] Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses
    Xu, Ke
    Lu, Weinan
    Yu, Airu
    Wu, Hongwei
    He, Jie
    BMC CANCER, 2024, 24 (01)
  • [30] Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
    La Fleur, Linnea
    Falk-Sorqvist, Elin
    Smeds, Patrik
    Berglund, Anders
    Sundstrom, Magnus
    Mattsson, Johanna S. M.
    Branden, Eva
    Koyi, Hirsh
    Isaksson, Johan
    Brunnstrom, Hans
    Nilsson, Mats
    Micke, Patrick
    Moens, Lotte
    Botling, Johan
    LUNG CANCER, 2019, 130 : 50 - 58
12345